Significant Progress, Tiny Float, Hot Junior Gold Mining Company U.S. Gold to Drill at Their Keystone Project Good day everyone, Today we are again in...
FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis
Article Link: FDA Approves Dupixent (dupilumab) as First Biologic Medicine for Children Aged 6 to 11 Years with Moderate-to-Severe Atopic Dermatitis...
Happy Memorial Day, please be safe, New tiny float NASDAQ report will be available tomorrow 5/26/20 at market open
New NASDAQ Report Will Be Available Tomorrow How Could Reopening Non-Essential Operations Impact Stocks? Good day everyone, As the world begins to reo...
New Low Float NASDAQ Report Coming 5/26/20 at Market Open. New Free Mine-able Cryptocurrency Inside This Report.
Opportunities beyond Memorial Day Long Holiday Weekend, NASDAQ Report Next Week and Free Mineable Cryptocurrency Good day everyone, The Memorial Day w...
FDA Approves Takeda’s Alunbrig (brigatinib) as a First-Line Treatment Option for Patients with ALK+ Metastatic Non-Small Cell Lung Cancer (NSCLC)
Article Link: FDA Approves Takeda’s Alunbrig (brigatinib) as a First-Line Treatment Option for Patients with ALK+ Metastatic Non-Small Cell Lung Cance...
FDA Approves Phexxi (lactic acid, citric acid and potassium bitartrate) Non-Hormonal Prescription Gel for the Prevention of Pregnancy
Article Link: FDA Approves Phexxi (lactic acid, citric acid and potassium bitartrate) Non-Hormonal Prescription Gel for the Prevention of Pregnancy...
FDA Approves Kynmobi (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes
Article Link: FDA Approves Kynmobi (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson’s Disease OFF Episodes MARL...
Chiesi Group Receives FDA Approval for Ferriprox (deferiprone) Twice-a-Day Tablets
Article Link: Chiesi Group Receives FDA Approval for Ferriprox (deferiprone) Twice-a-Day Tablets BOSTON, May 21, 2020 (GLOBE NEWSWIRE) ...
Lynparza Approved in the US for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
Article Link: Lynparza Approved in the US for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer 20 May 2020 — AstraZ...
FDA Approves Genentech’s Tecentriq as a First-Line Monotherapy for Certain People With Metastatic Non-Small Cell Lung Cancer
Article Link: FDA Approves Genentech’s Tecentriq as a First-Line Monotherapy for Certain People With Metastatic Non-Small Cell Lung Cancer ...